TAUNI KAYE: Open Payments
NPI 1245525955 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,012 in 26 payments from 6 companies in 2025. Trend: 2023 $126 · 2024 $528 · 2025 $2,012
Travel & lodging: $1,362Food & beverage: $615Education: $36
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 13 | $1,756 |
| ABBVIE INC. | 8 | $145 |
| Astellas Pharma US Inc | 2 | $56 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
Products named: INTERSTIM, QULIPTA, Veozah, UBRELVY, MYFEMBREE, LILETTA, INJECTAFER, Wegovy.
Industry payments across ID — which companies pay providers there.
